Skip to NavigationSkip to content

Pharmafile - Manufacturing and Production

Bristol-Myers Squibb has agreed to sell off Celgene’s psoriasis treatment Otezla, to appease antitrust regulators.
Drugmakers sue Trump over pricing ads, more warnings over the impact of a no-deal Brexit on medicines access and pricing, and scientists uncover the...
Bristol-Myers Squibb has reached an agreement with Catalent for the latter to acquire its Anagni, Italy-based facility which specialises in the...
The Healthcare Distribution Association (HDA) has warned MPs that Britain could face shortages of medicines if it were to leave the European Union...

Features

Characterised by a persistent lack of clarity and a political climate that has everyone guessing from week to week, Brexit appears as an...

Appointments

The Institute of Cancer Research (ICR) has said GlaxoSmithKline’s Dr Adrian Cottrell will join as the institute’s new Chief Information Officer....

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches